Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

HRS: Watchman bumps out warfarin in PROTECT AF

The Watchman wait may be over. An analysis of long-term data found the Watchman left atrial appendage closure device to be superior to warfarin for primary efficacy and mortality.

HRS: Registry data point to shortfall in anticoagulant therapy

Patients with paroxysmal atrial fibrillation (AF) were less likely to receive guideline recommended anticoagulation therapy compared with persistent AF patients. The analysis presented May 8 at the Heart Rhythm Society scientific sessions in Denver included registry data on more than 62,000 patients.

HRS: Societies share goals in joint sessions

Anne M. Gillis, MD, president of the Heart Rhythm Society and a professor at the University of Calgary, will co-chair a joint session on clinical registries on May 9 at Heart Rhythm 2013 in Denver. In a Q&A with Cardiovascular Business, she discussed the evolution of joint sessions and other program details.

HRS: Lead management, ablation updates on tap at meeting

Heart Rhythm Society (HRS) will offer new sessions as well as topics that were well received at previous meetings for its 2013 scientific sessions scheduled May 8-11 in Denver.

Electrophysiology devices market worth US$4.4 billion by 2015

Global electrophysiology devices market forecasts to reach at US$4.4 billion by 2015 at a CAGR of 9.7% during the analysis period 2009-2015. The North American segment accounts for nearly 35% of the global value while Europe claims approximately 30% of the market. Asia-Pacific is the fastest growing region with a CAGR of 10.8% driving a market value of US$1.1 billion by 2015.

Find out if your cath/EP lab is paying competitive wages

Cath/EP and interventional lab professionals wondering if their pay is competitive are being offered an objective measuring stick from a new research poll, Phoenix-based Springboard Healthcare announced.

Report: Global electrophysiology device market to reach $1.6B

The global electrophysiology device market, valued at $1.1 billion in 2010, is set to expand 6 percent, to reach $1.6 billion by 2017, according to an October report released by GlobalData, an industry analysis firm. The company said that the growing number of patients diagnosed with arrhythmias and the adoption of newer, robotic and magnetic navigation systems and drugs to treat atrial fibrillation will likely be the driver of this market growth.

The Networked EP Lab

New for Heart Rhythm 2011, the Networked EP Lab will prepare electrophysiologists for the future of health information technology (HIT). Visitors will discover new processes and technologies to integrate into the EP Lab to optimize patient safety, outcomes and improve procedural management and outcomes.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.